Published in Lancet on September 29, 2013
NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. Am J Respir Crit Care Med (2015) 2.60
Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits. Am J Hum Genet (2017) 1.06
Clinical intuition ratings are associated with morbidity and hospitalisation. Int J Clin Pract (2015) 0.92
Coronary artery disease risk assessment from unstructured electronic health records using text mining. J Biomed Inform (2015) 0.90
National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025. Am J Public Health (2015) 0.89
Ten-year blood pressure trajectories, cardiovascular mortality, and life years lost in 2 extinction cohorts: the Minnesota Business and Professional Men Study and the Zutphen Study. J Am Heart Assoc (2015) 0.88
Timeline of History of Hypertension Treatment. Front Cardiovasc Med (2016) 0.86
Arterial structure and function in vascular ageing: are you as old as your arteries? J Physiol (2015) 0.86
Validation of Health Event Capture in the Marshfield Epidemiologic Study Area. Clin Med Res (2014) 0.84
Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic heart disease. Int J Impot Res (2015) 0.82
Heme Oxygenases in Cardiovascular Health and Disease. Physiol Rev (2016) 0.82
Long-Term Effects of Childhood Risk Factors on Cardiovascular Health During Adulthood. Clin Med Rev Vasc Health (2015) 0.81
How far from the SNP may the causative genes be? Nucleic Acids Res (2016) 0.79
The imperative for health promotion in universal health coverage. Glob Health Sci Pract (2014) 0.79
Leveraging human genetics to guide drug target discovery. Trends Cardiovasc Med (2016) 0.78
The Incidence of Major Cardiovascular Events in Immigrants to Ontario, Canada: The CANHEART Immigrant Study. Circulation (2015) 0.78
Metabolism rather than obesity is associated with ischemic stroke: a cross-sectional study in rural Northeastern China. Springerplus (2016) 0.77
Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutr J (2015) 0.77
The human subject: an integrative animal model for 21(st) century heart failure research. Am J Transl Res (2015) 0.77
Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative. Clin Nutr (2016) 0.77
Development and application of chronic disease risk prediction models. Yonsei Med J (2014) 0.77
Genetically contextual effects of smoking on genome wide DNA methylation. Am J Med Genet B Neuropsychiatr Genet (2017) 0.76
Are There Still Too Few Suicides to Generate Public Outrage? JAMA Psychiatry (2016) 0.76
Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J (2016) 0.76
Pharmacological postconditioning with lactic acid and hydrogen rich saline alleviates myocardial reperfusion injury in rats. Sci Rep (2015) 0.76
The Jackson Heart KIDS Pilot Study: Theory-Informed Recruitment in an African American Population. J Racial Ethn Health Disparities (2016) 0.75
Framingham risk score in impaired glucose tolerant population: A sub analysis of Diabetes Prevention and Awareness Program of Pakistan. Pak J Med Sci (2016) 0.75
Multipronged Therapeutic Effects of Chinese Herbal Medicine Qishenyiqi in the Treatment of Acute Myocardial Infarction. Front Pharmacol (2017) 0.75
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review. Clin Kidney J (2016) 0.75
Northern Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design. BMJ Open (2017) 0.75
Hierarchical Bayesian Logistic Regression to forecast metabolic control in type 2 DM patients. AMIA Annu Symp Proc (2017) 0.75
Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics. J Med Internet Res (2016) 0.75
Stigmata of death: for kidneys and patients. Nephrol Dial Transplant (2014) 0.75
Physiological health parameters among college students to promote chronic disease prevention and health promotion. Prev Med Rep (2017) 0.75
Diet, life-style and cardiovascular morbidity in the rural, free living population of Elafonisos island. BMC Public Health (2017) 0.75
What we know and what we don't know about preventing stroke. PLoS Med (2014) 0.75
Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines. PLoS One (2016) 0.75
Genome-wide association meta-analyses identified 1q43 and 2q32.2 for hip Ward's triangle areal bone mineral density. Bone (2016) 0.75
What can cohort studies in the dog tell us? Canine Genet Epidemiol (2014) 0.75
Systems Medicine as an Emerging Tool for Cardiovascular Genetics. Front Cardiovasc Med (2016) 0.75
Mapping Atheroprotective Functions and Related Proteins/Lipoproteins in Size Fractionated Human Plasma. Mol Cell Proteomics (2017) 0.75
stpm: an R package for stochastic process model. BMC Bioinformatics (2017) 0.75
Long-term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later Life Body Size and Blood Pressure: The Bogalusa Heart Study. Circ Res (2017) 0.75
Cohort description: The Danish study of Functional Disorders. Clin Epidemiol (2017) 0.75
Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile using Historical Data. Circ Cardiovasc Genet (2016) 0.75
Metabolic Syndrome Is a Strong Risk Factor for Minor Ischemic Stroke and Subsequent Vascular Events. PLoS One (2016) 0.75
Patient-Specific Predictive Modeling Using Random Forests: An Observational Study for the Critically Ill. JMIR Med Inform (2017) 0.75
ST2L Transmembrane Receptor Expression: An Immunochemical Study on Endarterectomy Samples. PLoS One (2016) 0.75
Qingdao Port Cardiovascular Health Study: a prospective cohort study. BMJ Open (2015) 0.75
Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study. Ther Clin Risk Manag (2016) 0.75
Low oxygen saturation and mortality in an adult cohort: the Tromsø study. BMC Pulm Med (2015) 0.75
Weak prediction power of the Framingham Risk Score for coronary artery disease in nonagenarians. PLoS One (2014) 0.75
Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding. World J Gastroenterol (2017) 0.75
NHLBI Strategic Visioning: setting an agenda together for the NHLBI of 2025. Blood (2015) 0.75
Acute Bilateral Internal Carotid Occlusion from Embolization of Left Atrial Thrombus During Transesophageal Echocardiography: Case Report. J Vasc Interv Neurol (2016) 0.75
Framingham Contribution to Cardiovascular Disease. Heart Views (2016) 0.75
Human genetic variation and the gut microbiome in disease. Nat Rev Genet (2017) 0.75
Fried potato consumption is associated with elevated mortality: an 8-y longitudinal cohort study. Am J Clin Nutr (2017) 0.75
Lifestyle Medicine and the Management of Cardiovascular Disease. Curr Cardiol Rep (2017) 0.75
Towards a systems approach for chronic diseases, based on health state modeling. F1000Res (2017) 0.75
The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates. Curr Atheroscler Rep (2017) 0.75
On the potential of academic epidemiology. Eur J Epidemiol (2017) 0.75
Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals. Int Arch Occup Environ Health (2014) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health (1951) 20.27
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis (1967) 7.51
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J (1964) 5.17
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
Coronary heart disease in the Framingham study. Am J Public Health Nations Health (1957) 4.13
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation (2003) 3.46
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Blood-sugar and arterial disease. Lancet (1965) 2.70
Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA (1977) 2.60
Measuring the risk of coronary heart disease in adult population groups. The clinical status of a population group in Los Angeles under observation for two to three years. Am J Public Health Nations Health (1957) 2.28
Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med (1970) 1.67
SIR JAMES MACKENZIE'S HEART. Br Heart J (1939) 1.61
VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY. Am J Public Health Nations Health (1965) 1.56
Arteriosclerotic heart disease in diabetes mellitus; a clinical study of 383 patients. Am J Med (1955) 1.48
Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens (2000) 1.45
Serum cholesterol and relative body weight of coronary patients in different populations. Circulation (1960) 1.44
Acute myocardial infarction in 258 cases of diabetes. Immediate mortality and five-year survival. N Engl J Med (1965) 1.29
The prevalence of congestive heart failure in two rural communities. J Chronic Dis (1966) 1.26
Heart disease in old age. Postgrad Med J (1963) 1.20
Systolic hypertension: a pathogenetic entity. Significance and therapeutic considerations. Am J Cardiol (1962) 1.20
Cardiac complications of diabetes mellitus. Am J Med (1949) 1.19
Heart failure in hypertensive patients. Am Heart J (1963) 1.08
"A change of heart: how the people of framingham, massachusetts, helped unravel the mysteries of cardiovascular disease". Discov Med (2005) 1.02
Classics in arteriosclerosis research: On experimental cholesterin steatosis and its significance in the origin of some pathological processes by N. Anitschkow and S. Chalatow, translated by Mary Z. Pelias, 1913. Arteriosclerosis (1983) 1.00
Bishop lecture. Contribution of the Framingham Study to preventive cardiology. J Am Coll Cardiol (1990) 0.96
Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947-70). Int J Epidemiol (2006) 0.95
Risk factors and coronary heart disease--facts or fancy? Am Heart J (1976) 0.93
History of the Council on Epidemiology and Prevention, American Heart Association. The pursuit of epidemiology within the American Heart Association: prehistory and early organization. Circulation (1995) 0.81
Ancel Keys. Lancet (2004) 0.79
Longevity of man: relative weight and fatness in middle age. Ann Med (1989) 0.78
Etiology of congestive heart failure in clinical medicine. Ann N Y Acad Sci (1969) 0.78